Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

12871 ARTÍCULOS , VIENDO DEL 3931 AL 3945

New Nonsense Variant c.2983G>T; p.Glu995* in the CACNA1A Gene Causes Progressive Autosomal Dominant Ataxia

Saathoff Y, Biskup S, Funke C, Roth C.

J Mov Disord. 2021 Jan;14(1):70-74. doi: 10.14802/jmd.20082. Epub 2020 Oct 31.

Sialidosis Type I without a Cherry Red Spot- Is There a Genetic Basis?

Neeraja K, Holla VV, Prasad S, Surisetti BK, Rakesh K, Kamble N, Yadav R, Pal PK.

J Mov Disord. 2021 Jan;14(1):65-69. doi: 10.14802/jmd.20083. Epub 2020 Oct 31.

Pathologic Complete Response in Patient With ATM Mutation After Neoadjuvant FOLFOXIRI Plus Panitumumab Therapy for Locally Advanced Colon Cancer: A Case Report

McGillivray E, Farma J, Savage M, Hall MJ, Luo B, Jain R.

Clin Colorectal Cancer. 2021 Jun;20(2):e96-e99. doi: 10.1016/j.clcc.2020.09.004. Epub 2020 Sep 18.

An Overview of the Ferroptosis Hallmarks in Friedreich's Ataxia

Turchi R, Faraonio R, Lettieri-Barbato D, Aquilano K.

Biomolecules. 2020 Oct 28;10(11):1489. doi: 10.3390/biom10111489.

A unique finding of the basilar artery

Gnanadev R, Iwanaga J, Loukas M, Tubbs RS, Griessenauer CJ.

Surg Radiol Anat. 2021 Feb;43(2):301-303. doi: 10.1007/s00276-020-02607-3. Epub 2020 Nov 1.

Expanding the molecular spectrum and the neurological phenotype related to CAMTA1 variants

Jacobs EZ, Brown K, Byler MC, D'haenens E, Dheedene A, Henderson LB, Humberson JB, van Jaarsveld RH, Kanani F, Lebel RR, Millan F, Oegema R, Oostra A, Parker MJ, Rhodes L, Saenz M, Seaver LH, Si Y, Vanlander A, Vergult S, Callewaert B.

Clin Genet. 2021 Feb;99(2):259-268. doi: 10.1111/cge.13874. Epub 2020 Nov 23.

Loss of CBY1 results in a ciliopathy characterized by features of Joubert syndrome

Epting D, Senaratne LDS, Ott E, Holmgren A, Sumathipala D, Larsen SM, Wallmeier J, Bracht D, Frikstad KM, Crowley S, Sikiric A, Barøy T, Käsmann-Kellner B, Decker E, Decker C, Bachmann N, Patzke S, Phelps IG, Katsanis N, Giles R, Schmidts M, Zucknick M, Lienkamp SS, Omran H, Davis EE, Doherty D, Strømme P, Frengen E, Bergmann C, Misceo D.

Hum Mutat. 2020 Dec;41(12):2179-2194. doi: 10.1002/humu.24127. Epub 2020 Nov 1.

The Impact of Compulsivity and Impulsivity in Cerebellar Ataxia: A Case Series

Amokrane N, Lin CR, Desai NA, Kuo SH.

Tremor Other Hyperkinet Mov (N Y). 2020 Oct 16;10:43. doi: 10.5334/tohm.550.

Feasibility Case Study for Treating a Patient with Sensory Ataxia Following a Stroke with Kinesthetic Illusion Induced by Visual Stimulation

Aoyama T, Kanazawa A, Kohno Y, Watanabe S, Tomita K, Kimura T, Endo Y, Kaneko F.

Prog Rehabil Med. 2020 Oct 28;5:20200025. doi: 10.2490/prm.20200025. eCollection 2020.

SQSTM1 mutation: Description of the first Tunisian case and literature review

Akkari M, Kraoua I, Klaa H, Benrhouma H, Ben Younes T, Rouissi A, Chaabouni M, Ben Youssef-Turki I.

Mol Genet Genomic Med. 2020 Dec;8(12):e1543. doi: 10.1002/mgg3.1543. Epub 2020 Nov 2.

Cochlear Implantation Outcomes in Post Synaptic Auditory Neuropathies: A Systematic Review and Narrative Synthesis

Chaudhry D, Chaudhry A, Muzaffar J, Monksfield P, Bance M.

J Int Adv Otol. 2020 Dec;16(3):411-431. doi: 10.5152/iao.2020.9035.

ACE2 and gut amino acid transport

Camargo SMR, Vuille-Dit-Bille RN, Meier CF, Verrey F.

Clin Sci (Lond). 2020 Nov 13;134(21):2823-2833. doi: 10.1042/CS20200477.

Retrospective evaluation of the effects and outcome of bromethalin ingestion: 192 Dogs (2010-2016)

Scotti KM, Levy NA, Thomas A, Pfeifer J, Garcia N, Koenigshof A.

J Vet Emerg Crit Care (San Antonio). 2021 Jan;31(1):94-98. doi: 10.1111/vec.13026. Epub 2020 Nov 3.

Bone Marrow Transplantation as Therapy for Ataxia-Telangiectasia: A Systematic Review

Sabino Pinho de Oliveira B, Putti S, Naro F, Pellegrini M.

Cancers (Basel). 2020 Oct 31;12(11):3207. doi: 10.3390/cancers12113207.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias